Alcoholics should not be subject to deprioritization on a liver transplant waiting list if the belief is held that alcoholism is a disease and not an issue of moral failure for which the patient should be blamed.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
A recent journal article calls for a public policy that would require physician-researchers to demonstrate the absence of undue influence or coercion on informed consent.
The journal invites students to share their medical training observations captured in photographs by highlighting a drawing of a DNA double helix as a symbol for the role of ethics in genetic research.